First Time Loading...

RemeGen Co Ltd
HKEX:9995

Watchlist Manager
RemeGen Co Ltd Logo
RemeGen Co Ltd
HKEX:9995
Watchlist
Price: 30.5 HKD 0.83% Market Closed
Updated: Apr 28, 2024

Intrinsic Value

RemeGen Co Ltd's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of innovative biopharmaceuticals. [ Read More ]

The intrinsic value of one RemeGen Co Ltd stock under the Base Case scenario is 39.32 HKD. Compared to the current market price of 30.5 HKD, RemeGen Co Ltd is Undervalued by 22%.

Key Points:
Intrinsic Value
Base Case
39.32 HKD
Undervaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
RemeGen Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling RemeGen Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
RemeGen Co Ltd

Provide an overview of the primary business activities
of RemeGen Co Ltd.

What unique competitive advantages
does RemeGen Co Ltd hold over its rivals?

What risks and challenges
does RemeGen Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for RemeGen Co Ltd.

Provide P/S
for RemeGen Co Ltd.

Provide P/E
for RemeGen Co Ltd.

Provide P/OCF
for RemeGen Co Ltd.

Provide P/FCFE
for RemeGen Co Ltd.

Provide P/B
for RemeGen Co Ltd.

Provide EV/S
for RemeGen Co Ltd.

Provide EV/GP
for RemeGen Co Ltd.

Provide EV/EBITDA
for RemeGen Co Ltd.

Provide EV/EBIT
for RemeGen Co Ltd.

Provide EV/OCF
for RemeGen Co Ltd.

Provide EV/FCFF
for RemeGen Co Ltd.

Provide EV/IC
for RemeGen Co Ltd.

Show me price targets
for RemeGen Co Ltd made by professional analysts.

What are the Revenue projections
for RemeGen Co Ltd?

How accurate were the past Revenue estimates
for RemeGen Co Ltd?

What are the Net Income projections
for RemeGen Co Ltd?

How accurate were the past Net Income estimates
for RemeGen Co Ltd?

What are the EPS projections
for RemeGen Co Ltd?

How accurate were the past EPS estimates
for RemeGen Co Ltd?

What are the EBIT projections
for RemeGen Co Ltd?

How accurate were the past EBIT estimates
for RemeGen Co Ltd?

Compare the revenue forecasts
for RemeGen Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of RemeGen Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of RemeGen Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of RemeGen Co Ltd compared to its peers.

Compare the P/E ratios
of RemeGen Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing RemeGen Co Ltd with its peers.

Analyze the financial leverage
of RemeGen Co Ltd compared to its main competitors.

Show all profitability ratios
for RemeGen Co Ltd.

Provide ROE
for RemeGen Co Ltd.

Provide ROA
for RemeGen Co Ltd.

Provide ROIC
for RemeGen Co Ltd.

Provide ROCE
for RemeGen Co Ltd.

Provide Gross Margin
for RemeGen Co Ltd.

Provide Operating Margin
for RemeGen Co Ltd.

Provide Net Margin
for RemeGen Co Ltd.

Provide FCF Margin
for RemeGen Co Ltd.

Show all solvency ratios
for RemeGen Co Ltd.

Provide D/E Ratio
for RemeGen Co Ltd.

Provide D/A Ratio
for RemeGen Co Ltd.

Provide Interest Coverage Ratio
for RemeGen Co Ltd.

Provide Altman Z-Score Ratio
for RemeGen Co Ltd.

Provide Quick Ratio
for RemeGen Co Ltd.

Provide Current Ratio
for RemeGen Co Ltd.

Provide Cash Ratio
for RemeGen Co Ltd.

What is the historical Revenue growth
over the last 5 years for RemeGen Co Ltd?

What is the historical Net Income growth
over the last 5 years for RemeGen Co Ltd?

What is the current Free Cash Flow
of RemeGen Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for RemeGen Co Ltd.

Financials

Balance Sheet Decomposition
RemeGen Co Ltd

Current Assets 2.2B
Cash & Short-Term Investments 726.6m
Receivables 473.5m
Other Current Assets 1B
Non-Current Assets 3.3B
Long-Term Investments 98.2m
PP&E 3B
Intangibles 143.8m
Other Non-Current Assets 20.8m
Current Liabilities 1.1B
Accounts Payable 125.3m
Accrued Liabilities 224.2m
Short-Term Debt 301.4m
Other Current Liabilities 477.1m
Non-Current Liabilities 962.9m
Long-Term Debt 915.3m
Other Non-Current Liabilities 47.6m
Efficiency

Earnings Waterfall
RemeGen Co Ltd

Revenue
1.1B CNY
Cost of Revenue
-257.3m CNY
Gross Profit
825.7m CNY
Operating Expenses
-2.3B CNY
Operating Income
-1.5B CNY
Other Expenses
3.9m CNY
Net Income
-1.5B CNY

Free Cash Flow Analysis
RemeGen Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

Profitability Score
Profitability Due Diligence

RemeGen Co Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 1-Year Revenue Growth
Negative Operating Income
30/100
Profitability
Score

RemeGen Co Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

RemeGen Co Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
70/100
Solvency
Score

RemeGen Co Ltd's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
RemeGen Co Ltd

Wall Street analysts forecast RemeGen Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RemeGen Co Ltd is 44.93 HKD with a low forecast of 40.71 HKD and a high forecast of 48.79 HKD.

Lowest
Price Target
40.71 HKD
33% Upside
Average
Price Target
44.93 HKD
47% Upside
Highest
Price Target
48.79 HKD
60% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
RemeGen Co Ltd

1M 1M
+12%
6M 6M
-29%
1Y 1Y
-33%
3Y 3Y
-73%
5Y 5Y
-56%
10Y 10Y
-56%
Annual Price Range
30.5
52w Low
15.22
52w High
47.5
Price Metrics
Average Annual Return 0.71%
Standard Deviation of Annual Returns 42.75%
Max Drawdown -89%
Shares Statistics
Market Capitalization 31.6B HKD
Shares Outstanding 1 035 300 006
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

RemeGen Co Ltd Logo
RemeGen Co Ltd

Country

China

Industry

Biotechnology

Market Cap

31.6B HKD

Dividend Yield

0%

Description

RemeGen Co Ltd is a China-based company mainly engaged in the research, development and manufacture of innovative biopharmaceuticals. The Company is mainly engaged in the discovery, development and commercialization of therapeutic antibody drugs such as antibody drug conjugates (ADCs), antibody fusion proteins, monoclonal antibodies and bispecific antibodies. The Company's main products include tetacept (RC18), veldicitumab (RC48) and dual-target fusion protein (RC28). The Company's products are mainly used to treat major diseases such as autoimmune diseases, oncology and ophthalmology. The Company mainly conducts its businesses in the domestic market.

Contact

SHANDONG
Yantai
No. 58, Beijing Middle Road, Yantai Development Zone
+865356113681.0
http://www.remegen.cn/

IPO

2020-11-09

Employees

1 735

Officers

Co-Founder, CEO,Member of Scientific Advisory Board & Executive Director
Dr. Jianmin Fang
Chief Medical Officer, Head of Clinical Research, Member of Scientific Adv. Board & Executive Dir.
Dr. Ruyi He M.D.
Executive Director
Mr. Jian Lin
CFO & Joint Company Secretary
Mr. Shaojing Tong
Chief Operating Officer
Mr. Kaisheng Huang
Chief Technical Officer
Dr. Marie Zhu
Show More
Chief Scientific Officer
Dr. Zhulun Wang
Chief Business Officer
Mr. Daniel R. Ross
Chief Manufacturing Officer
Dr. Xiaoming Yang Ph.D.
Joint Company Secretary
Ms. Pak Yu Tam A.C.I.S., A.C.S.
Show Less

See Also

Discover More
What is the Intrinsic Value of one RemeGen Co Ltd stock?

The intrinsic value of one RemeGen Co Ltd stock under the Base Case scenario is 39.32 HKD.

Is RemeGen Co Ltd stock undervalued or overvalued?

Compared to the current market price of 30.5 HKD, RemeGen Co Ltd is Undervalued by 22%.